integrated solutions for glp-1 and peptides Advances in GLP-1 receptor agonists

Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells

While oral NAC would be the first mutation-independent therapy available for RP patients, additional options with less frequent and more targeted dosing would be advantageous to patients managing a life-long chronic disease

Li Y, Ma QG, Zhao LH, Guo YQ, Duan GX, Zhang JY, Ji C (2014) Protective efficacy of alpha-lipoic acid against aflatoxinB1-induced oxidative damage in the liver

Interface Sci

10.1038/s42255-020-00310-6 Nat Metab

Register here: To view or add a comment, sign in Im seeing a lot of questions lately about GLP1sespecially as interest and utilization continue to climb